GE HealthCare Technologies Inc. (GEHC)
(Delayed Data from NSDQ)
$69.85 USD
-1.47 (-2.06%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $70.07 +0.22 (0.31%) 7:58 PM ET
1-Strong Buy of 5 1
B Value F Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
GEHC 69.85 -1.47(-2.06%)
Will GEHC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GEHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GEHC
OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands
GEHC vs. BSX: Which Stock Is the Better Value Option?
GEHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises
Compared to Estimates, GE HealthCare (GEHC) Q2 Earnings: A Look at Key Metrics
GE HealthCare Technologies (GEHC) Q2 Earnings and Revenues Top Estimates
Other News for GEHC
GEHC: Morgan Stanley Maintains Equal-Weight, Lowers Price Target | GEHC Stock News
GEHC: Citigroup Maintains Buy Rating, Raises Price Target to $93 | GEHC Stock News
GE HealthCare price target raised by $6 at Citi, here's why
GEHC: Citi Boosts Price Target Amid Robust Pipeline
GE HealthCare price target raised by $4 at Citi, here's why